The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Open accessAbstract
The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide. Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair. However, a dysregulated macrophage response can be damaging to the host, as is seen in the macrophage activation syndrome induced by severe infections, including in infections with the related virus SARS-CoV. Here we describe the potentially pathological roles of macrophages during SARS-CoV-2 infection and discuss ongoing and prospective therapeutic strategies to modulate macrophage activation in patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the host itself seems to be the major factor explaining disease severity, infection rates (Merad and Martin, 2020; Vabret et al., 2020), and long-term medical consequences (Marshall, 2020).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Merad and Martin, 2020
In the citing paper
“Cytokines that mediate manifestations of ARDS, like IL-6 and TNFα, can also facilitate vascular permeability, systemic shock and multi-organ failure41,51.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Cited by
Sorted by citations
Items 501–600 of 1,002
Xiong, S., Zhang, L., Qadir, A. S., Richner, J. M., Class, J., Rehman, J., & Malik, A. B. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316925 · Cited by 48
Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19
Peyneau, M., Granger, V., Wicky, P.-H., Khelifi‐Touhami, D., Timsit, J., Lescure, F.-X., Yazdanpanah, Y., Tran‐Dinh, A., Montravers, P., Monteiro, R. C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04705-7 · Cited by 52
Polyglycerols as Multi-Functional Platforms: Synthesis and Biomedical Applications
Pouyan, P., Cherri, M., & Haag, R. (2022) · Polymers · doi:10.3390/polym14132684 · Cited by 46
Ying, B., Darling, T. L., Desai, P., Liang, C.-Y., Dmitriev, I. P., Soudani, N., Bricker, T. L., Kashentseva, E. A., Harastani, H., Raju, S., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01743-x · Cited by 49
Villena, J., Li, C., Vizoso-Pinto, M. G., Sacur, J., Ren, L., & Kitazawa, H. (2021) · Microorganisms · doi:10.3390/microorganisms9040683 · Cited by 45
Wang, X., Xin, B., Tan, W., Xu, Z., Li, K., Li, F., Zhong, W., & Peng, S. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab226 · Cited by 44
Danilenko, V., Devyatkin, A., Marsova, M., Shibilova, M., Ilyasov, R. A., & Shmyrev, V. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s333887 · Cited by 54
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Prasanna, P. G. S., Woloschak, G. E., DiCarlo, A. L., Buchsbaum, J. C., Schaue, D., Chakravarti, A., Cucinotta, F. A., Formenti, S. C., Guha, C., Hu, D. J., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00211.1 · Cited by 45
Trombetta, A. C., Farias, G. B., Gomes, A. M. C., Godinho‐Santos, A., Rosmaninho, P., Conceição, C. M., Laia, J., Santos, D. F., Almeida, A. R. M., Mota, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691725 · Cited by 48
Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study
Chang, Y., Jeon, J., Song, T., & Kim, J. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.06.014 · Cited by 45
Labzin, L. I., Chew, K. Y., Eschke, K., Wang, X., Esposito, T., Stocks, C. J., Rae, J. A., Patrick, R., Mostafavi, H., Hill, B., et al. (2023) · Science Signaling · doi:10.1126/scisignal.abq1366 · Cited by 45
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Chen, M., Pekosz, A. S., Villano, J., Shen, W., Zhou, R., Kulaga, H. M., Li, Z., Smith, A. K., Gurung, A., Beck, S. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174439 · Cited by 52
Zhao, G., Gentile, M. E., Xue, L., Cosgriff, C. V., Weiner, A. I., Adams‐Tzivelekidis, S., Wong, J., Li, X., Kass-Gergi, S., Holcomb, N. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48589-3 · Cited by 46
COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings
Öztürk, R., Taşova, Y., & Ayaz, A. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2005-287 · Cited by 53
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
Persoons, L., Vanderlinden, E., Vangeel, L., Wang, X., Dan, T. N., Foo, C. S.-Y., Leyssen, P., Neyts, J. H., Jochmans, D., Schols, D., et al. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105127 · Cited by 47
SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-ĸB Activation
Xia, J. L., Tang, W., Wang, J., Lai, D., Xu, Q., Huang, R., Hu, Y., Gong, X., Fan, J., Shu, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791753 · Cited by 45
Semmarath, W., Mapoung, S., Umsumarng, S., Arjsri, P., Srisawad, K., Thippraphan, P., Yodkeeree, S., & Dejkriengkraikul, P. (2022) · Nutrients · doi:10.3390/nu14132738 · Cited by 45
Continuous tracking of COVID-19 patients' immune status
Guan, J., Wei, X., Qin, S., Liu, X., Jiang, Y., Chen, Y., Chen, Y., Lu, H., Qian, J., Wang, Z., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107034 · Cited by 49
Pergolizzi, J. V., LeQuang, J. A., Varrassi, M., Breve, F., Magnusson, P., & Varrassi, G. (2023) · Advances in Therapy · doi:10.1007/s12325-022-02395-9 · Cited by 46
Vieira, C. C., Nery, L., Martins, L. D. B. U., Jabour, L. G. P. P., Dias, R. F., & Silva, A. C. S. E. (2020) · Current Drug Targets · doi:10.2174/1389450121666201020154033 · Cited by 46
Coagulation Disorders in COVID-19: Role of Toll-like Receptors
Biswas, I., & Khan, G. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s271768 · Cited by 45
SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure
Stasi, A., Castellano, G., Ranieri, E., Infante, B., Stallone, G., Gesualdo, L., & Netti, G. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124057 · Cited by 43
The Immunopathology of COVID-19 and the Cannabis Paradigm
Paland, N., Pechkovsky, A., Aswad, M., Hamza, H., Popov, T., Shahar, E., & Louria‐Hayon, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631233 · Cited by 46
Targeting immunometabolism to treat COVID-19
O’Carroll, S. M., & O'Neill, L. A. J. (2021) · Immunotherapy Advances · doi:10.1093/immadv/ltab013 · Cited by 44
Salleh, M. Z., Norazmi, M. N., & Deris, Z. Z. (2022) · PeerJ · doi:10.7717/peerj.13083 · Cited by 45
Schroeder, J. T., & Bieneman, A. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831763 · Cited by 46
Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
Shah, T., Shah, Z., Yasmeen, N., Baloch, Z., & Xia, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909011 · Cited by 49
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Wang, Z., Li, S., & Huang, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01106-8 · Cited by 48
A Review of Postmortem Findings in Patients With COVID-19
Eketunde, A. O., Mellacheruvu, S. P., & Oreoluwa, P. (2020) · Cureus · doi:10.7759/cureus.9438 · Cited by 43
Potential benefits of ginseng against COVID-19 by targeting inflammasomes
Yi, Y. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.03.008 · Cited by 43
Omoush, S. A., & Alzyoud, J. A. M. (2022) · Pathogens · doi:10.3390/pathogens11040445 · Cited by 44
Genetic susceptibility to severe COVID-19
Cappadona, C., Rimoldi, V., Paraboschi, E. M., & Asselta, R. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105426 · Cited by 52
Li, Y., Hook, J. S., Qing, D., Xiao, X., Chung, S. S., Mettlen, M., Xu, L., Moreland, J. G., & Agathocleous, M. (2023) · Nature Communications · doi:10.1038/s41467-023-37567-w · Cited by 49
Peng, S., Wang, H., Sun, X., Li, P., Ye, Z., Li, Q., Wang, J., Shi, X., Liu, L., Yao, Y., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa288 · Cited by 44
Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19
Kazancıoğlu, S., Yılmaz, F. M., Baştuğ, A., Sakallı, A., Özbay, B. O., Buyuktarakci, C., Bodur, H., & Yılmaz, G. (2020) · Viral Immunology · doi:10.1089/vim.2020.0166 · Cited by 45
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
Liao, M.-T., Wu, C., Wu, S. V., Lee, M., Hu, W., Tsai, K., Yang, C., Lu, C., Chiu, S.-K., & Lu, K. (2021) · Antioxidants · doi:10.3390/antiox10091440 · Cited by 46
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
Saini, K. S., Lanza, C., Romano, M., de Azambuja, E., Cortés, J., Heras, B. D. L., de Castro, J., Saini, M. L., Loibl, S., Curigliano, G., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0948-x · Cited by 38
Bertolazzi, G., Cipollina, C., Benos, P. V., Tumminello, M., & Coronnello, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.586592 · Cited by 42
Khoshkam, Z., Aftabı, Y., Stenvinkel, P., Lawrence, B. P., Habibi-Rezaei, M., Ichihara, G., & Fereidouni, S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2020.12.013 · Cited by 45
Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2
Agrawal, S., Salazar, J. V., Tran, T. M., & Agrawal, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739757 · Cited by 42
Li, Y., Li, H., Song, C., Lu, R., Zhao, Y., Lin, F., Han, D., Chen, L., Pan, P., & Dai, M. (2021) · Disease Markers · doi:10.1155/2021/6304189 · Cited by 44
Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
He, W., Liu, X., Hu, B., Li, D., Chen, L., Li, Y., Tu, Y., Xiong, S., Wang, G., Deng, J., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.838213 · Cited by 42
Maher, A. K., Burnham, K. L., Jones, E. M., Tan, M. M., Saputil, R. C., Baillon, L., Selck, C., Giang, N., Argüello, R. J., Pillay, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35638-y · Cited by 46
Wang, Y., Yang, S., Han, B., Du, X., Sun, H., Du, Y., Liu, Y., Lu, P., Di, J., Luu, L. D. W., et al. (2024) · iMeta · doi:10.1002/imt2.226 · Cited by 46
Zabozlaev, F., Кравченко, Е. В., Gallyamova, А. R., & Николаевич, Л. Н. (2020) · Journal of clinical practice · doi:10.17816/clinpract34849 · Cited by 42
The prognostic role of neopterin in COVID‐19 patients
Özger, H. S., Dizbay, M., Çorbacıoğlu, Ş. K., Yıldız, P. A., Demirbas, Z., Tunçcan, Ö. G., Hızel, K., Bozdayı, G., & Çağlar, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26472 · Cited by 42
Mucosal-associated invariant T cell responses differ by sex in COVID-19
Chen, Y., Littleton, S., Giroux, N. S., Mathew, R., Ding, S., Kalnitsky, J., Yang, Y., Petzold, E., Chung, H. A., Rivera, G. O., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.008 · Cited by 42
Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps
Bautista-Becerril, B., Campi-Caballero, R., Sevilla-Fuentes, S., Hernández-Regino, L. M., Hanono, A., Flores-Bustamante, A., González-Flores, J., García-Ávila, C., Aquino‐Gálvez, A., Castillejos-López, M. D. J., et al. (2021) · Biomolecules · doi:10.3390/biom11050694 · Cited by 44
Ripamonti, C., Spadotto, V., Pozzi, P., Stevenazzi, A., Vergani, B., Marchini, M., Sandrone, G., Bonetti, E., Mazzarella, L., Minucci, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841716 · Cited by 38
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium
Rello, J., Belliato, M., Dimopoulos, M. A., Giamarellos‐Bourboulis, E. J., Jaksic, V., Martín‐Loeches, I., Mporas, I., Pelosi, P. P., Poulakou, G., Pournaras, S., et al. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.10.008 · Cited by 41
Interstitial pneumonia and diffuse alveolar damage in domestic animals
Carvallo, F. R., & Stevenson, V. B. (2022) · Veterinary Pathology · doi:10.1177/03009858221082228 · Cited by 42
Bosteels, C., Damme, K. F. A. V., Leeuw, E. D., Declercq, J., Maes, B., Bosteels, V., Hoste, L., Naesens, L., Debeuf, N., Deckers, J., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100833 · Cited by 43
Harnessing Memory NK Cell to Protect Against COVID-19
Soleimanian, S., & Yaghobi, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01309 · Cited by 41
Ellison, G. M., Colley, L. S., O’Brien, K. A., Roberts, K. A., Agbaedeng, T. A., & Ross, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.602183 · Cited by 42
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
Aigner, L., Pietrantonio, F., de Sousa, D. M. B., Michael, J., Schuster, D., Reitsamer, H. A., Zerbe, H., & Studnicka, M. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.610132 · Cited by 40
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
Monschein, T., Hartung, H., Zrzavy, T., Barnett, M. H., Boxberger, N., Berger, T., Chataway, J., Bar‐Or, A., Rommer, P. S., & Zettl, U. K. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-326839 · Cited by 45
Rotoli, B. M., Barilli, A., Visigalli, R., Ferrari, F., & Dall’Asta, V. (2021) · Biomedicines · doi:10.3390/biomedicines9091220 · Cited by 43
Wijayasinghe, Y. S., Bhansali, M. P., Borkar, M. R., Chaturbhuj, G. U., Muntean, B. S., Viola, R. E., & Bhansali, P. R. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01737 · Cited by 41
A comprehensive review on potential therapeutics interventions for COVID-19
Chugh, H., Awasthi, A., Agarwal, Y., Gaur, R. K., Dhawan, G., & Chandra, R. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173741 · Cited by 44
Ntatsoulis, K., Karampitsakos, Τ., Tsitoura, E., Stylianaki, E.-A., Matralis, A. N., Tzouvelekis, A., Antoniou, K. M., & Aidinis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687397 · Cited by 41
Gaughan, E. E., Quinn, T. M., Mills, A., Bruce, A. M., Antonelli, J., MacKinnon, A. C., Aslanis, V., Li, F., O’Connor, R. A., Boz, C., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0477oc · Cited by 40
Li, L., Xu, W., Luo, Y., Lao, C., Tong, X., Du, J., Huang, B., Li, D., Chen, J., Ye, H., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120032 · Cited by 41
Zhu, B., Wei, X., Narasimhan, H., Qian, W. G., Zhang, R., Cheon, I. S., Wu, Y., Li, C., Jones, R. G., Kaplan, M. H., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adf0348 · Cited by 39
A bacterially engineered macrophage sponge as a neutralization decoy to treat bacterial infection
Cheng, G., Kwong, C. H. T., Tang, M., Liu, J., Kam, H., Li, S., Lee, S. M., Fan, C., Yu, H., & Wang, R. (2023) · Matter · doi:10.1016/j.matt.2023.09.007 · Cited by 40
Cheng, G., Wang, Q., Ding, Y., Kwong, C. H. T., Liu, J., Xie, B., Wei, J., Lee, S. M., Mok, G. S. P., & Wang, R. (2024) · Nature Communications · doi:10.1038/s41467-023-44662-5 · Cited by 41
Blanch‐Rubió, J., Soldevila‐Domenech, N., Tío, L., Llorente‐Onaindia, J., Recasens, M. C., Polino, L., Gurt, A., de la Torre, R., Maldonado, R. J., Monfort, J., et al. (2020) · Aging · doi:10.18632/aging.104117 · Cited by 40
Francescangeli, F., Angelis, M. L. D., Baiocchi, M., Rossi, R., Biffoni, M., & Zeuner, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.592891 · Cited by 41
A clinical primer for the expected and potential post-COVID-19 syndromes
Walitt, B. T., & Bartrum, E. A. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000887 · Cited by 45
The Role of Immunogenetics in COVID-19
Pojero, F., Candore, G., Caruso, C., Bona, D. D., Groneberg, D. A., Ligotti, M. E., Accardi, G., & Aiello, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052636 · Cited by 42
Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19
Maruhashi, T., & Higashi, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105131 · Cited by 40
Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2
Melvin, W. J., Audu, C. O., Davis, F. M., Sharma, S. B., Joshi, A., denDekker, A. D., Wolf, S., Barrett, E. C., Mangum, K. D., Zhou, X., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101071118 · Cited by 44
Nanoparticle approaches against SARS-CoV-2 infection
Duan, Y., Wang, S., Zhang, Q., Gao, W., & Zhang, L. (2021) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2021.100964 · Cited by 40
Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
Zhang, H., Shao, B., Dang, Q., Chen, Z., Zhou, Q., Luo, H., Yuan, W., & Sun, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674074 · Cited by 39
Marconato, M., Abela, I. A., Hauser, A., Schwarzmüller, M., Katzensteiner, R., Braun, D. L., Epp, S., Audigé, A., Weber, J., Rusert, P., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158190 · Cited by 45
Yan, D., Dai, C., Xu, R., Huang, Q., & Ren, W. (2022) · Gerontology · doi:10.1159/000524759 · Cited by 40
Cytokine Storm in COVID19: A Neural Hypothesis
Anoop, U. R., & Verma, K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00346 · Cited by 40
High-dimensional single-cell analysis reveals the immune characteristics of COVID-19
Shi, W., Liu, X., Cao, Q., Ma, P., Le, W., Xie, L., Ye, J., Wen, W., Tang, H., Su, W., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2020 · Cited by 40
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Reiter, R. J., Sharma, R., Šimko, F., Domínguez‐Rodríguez, A., Tesařík, J., Neel, R. L., Slominski, A. T., Kleszczyński, K., Martin-Gimenez, V. M., Manucha, W. A., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04102-3 · Cited by 39
Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach
Pandya, M. D., Shah, S., Dhanalakshmi, M., Juneja, T., Patel, A. J., Gadnayak, A., Dave, S., Das, K., & Das, J. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100951 · Cited by 39
Dutta, D., Liu, J., & Xiong, H. (2022) · PubMed Central · Cited by 38
Kerzhner, O., Berla, E., Har‐Even, M., Ratmansky, M., & Goor‐Aryeh, I. (2023) · Pain Practice · doi:10.1111/papr.13277 · Cited by 44
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
Cacciapuoti, S., Rosa, A. D., Gelzo, M., Megna, M., Raia, M., Pinchera, B., Pontarelli, A., Scotto, R., Scala, E., Scarano, F., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118355 · Cited by 39
Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19
Surnar, B., Kamran, M. Z., Shah, A. S., & Dhar, S. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00179 · Cited by 39
de Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 39
Laha, S., Saha, C., Dutta, S., Basu, M., Chatterjee, R., Ghosh, S. K., & Bhattacharyya, N. P. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06395 · Cited by 42
Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
Stegelmeier, A. A., Darzianiazizi, M., Hanada, K., Sharif, S., Wootton, S. K., Bridle, B. W., & Karimi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094726 · Cited by 41
ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages
Matsuo, K., Lepinski, A., Chavez, R. D., Barruet, E., Pereira, A., Moody, T. A., Ton, A. N., Sharma, A., Hellman, J., Tomoda, K., et al. (2021) · Bone · doi:10.1016/j.bone.2021.116129 · Cited by 43
Gómez‐Carballa, A., Calle, I. R., Pardo‐Seco, J., Rial, J. G., Rivero-Velasco, C., Rodríguez‐Núñez, N., Barbeito‐Castiñeiras, G., Pérez-Freixo, H., Cebey‐López, M., Barral‐Arca, R., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112890 · Cited by 39
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Tangye, S. G., Abel, L., Al-Muhsen, S., Aiuti, A., Al‐Muhsen, S., Al‐Mulla, F., Anderson, M. S., Andreakos, E., Novelli, A., Arias, A. A., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.010 · Cited by 38
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
Rowlands, M., Segal, F., & Hartl, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.697405 · Cited by 40
Genetically modified mouse models to help fight COVID-19
Gurumurthy, C. B., Quadros, R. M., Richardson, G. P., Poluektova, L. Y., Mansour, S. L., & Ohtsuka, M. (2020) · Nature Protocols · doi:10.1038/s41596-020-00403-2 · Cited by 39
MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity
Vega, M. A., Simón‐Fuentes, M., de la Aleja, A. G., Nieto, C., Colmenares, M., Herrero, C., Domínguez‐Soto, Á., & Corbí, A. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603507 · Cited by 37
Ambrosino, P., Molino, A., Calcaterra, I. L., Formisano, R., Stufano, S., Spedicato, G. A., Motta, A., Papa, A., Minno, M. N. D. D., & Maniscalco, M. (2021) · Biomedicines · doi:10.3390/biomedicines9060614 · Cited by 38
Policard, M., Jain, S. S., Rego, S., & Dakshanamurthy, S. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198464 · Cited by 38
Hammoudeh, S. M., Hammoudeh, A. M., Bhamidimarri, P. M., AlSafar, H. S., Mahboub, B. H., Künstner, A., Busch, H. S., Halwani, R., Hamid, Q. A., Rahmani, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.595150 · Cited by 38
Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
Temerozo, J. R., Rodrigues, N. F., dos Santos, M. C., Hottz, E. D., Sacramento, C. Q., da Silva, A. D. P. D., Mandacaru, S. C., Moraes, E. C. D. S., Trugilho, M. R. O., Gesto, J. S. M., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01260-9 · Cited by 45
Zarkoob, H., Allué‐Guardia, A., Chen, Y., Garcia‐Vilanova, A., Jung, O., Coon, S. L., Song, M. J., Park, J., Oladunni, F. S., Miller, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03753-7 · Cited by 37
Functional and druggability analysis of the SARS-CoV-2 proteome
Cavasotto, C. N., Sánchez‐Lamas, M., & Maggini, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173705 · Cited by 38
Chen, P., Tang, Y., He, W., Yang, R., Lan, Z., Chen, R., & Zhang, P. (2022) · Mediators of Inflammation · doi:10.1155/2022/7137900 · Cited by 40
Cross, A. R., de Andrea, C. E., Villalba-Esparza, M., Landecho, M. F., Cerundolo, L., Weeratunga, P. N., Etherington, R. E., Denney, L., Ogg, G. S., Ho, L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.157837 · Cited by 40
Metadata
- Authors
- Merad, M., & Martin, J. C.
- Affiliations
- Inserm (FR)
- Corresponding author
- Martin, Jerome C.
- ORCID
- Martin, Jerome C.
- Venue
- Nature Reviews Immunology
- Published
- 2020-05-06
- Volume
- 20
- Issue
- 6
- Pages
- 355-362
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7201395
- OpenAlex
- W3023982717
- Cited by
- 2,472
- References
- 65
- Citations by year
- 2026: 89 · 2025: 133 · 2024: 196 · 2023: 330 · 2022: 529 · 2021: 753 · 2020: 435
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-06-02)
- Open access
- bronze
- doi.org
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Icahn School of Medicine at Mount Sinai
- Agence Nationale de la Recherche (ANR-16-IDEX-0007)
- Institut National de la Santé et de la Recherche Médicale
- Université de Nantes
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- COVID-19 pandemic, SARS-CoV-2, monocytes, macrophages, hyperinflammation, macrophage activation syndrome, innate immunity, inflammatory signaling
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Humans, Inflammation, Macrophage Activation, Macrophages, Monocytes, Pneumonia, Viral, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
